TerminatedPhase 3NCT03940690
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
Studying Coats disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Principal Investigator
- Florence METGEfmetge@for.paris
- Intervention
- Anti-VEGF injections of bevacizumab(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2019 – 2023
Study locations (6)
- Centre hospitalier René Dubos (Pontoise), Cergy-Pontoise, France, France
- Hôpital Universitaire Necker Enfants Malades, APHP, Paris, France, France
- Fondation Ophtalmologique A. de Rothschild, Paris, France, France
- CHU de Reims, Reims, France, France
- Clinique Rive Gauche, Toulouse, France, France
- CHU de Bordeaux, Bourdeaux, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03940690 on ClinicalTrials.govOther trials for Coats disease
Additional recruiting or active studies for the same condition.